Chávez ADM, Casanova GMF, Capote PJL

Language: Spanish
References: 10
Page: 156-159
PDF size: 79.18 Kb.

ABSTRACT

Medicine development has shown the need of preventing transmissible diseases by means of Vaccines. After a description of the role of pneumococcus in the origin of diseases, a career towards preventing them was started. In the current century, the first conjugated vaccine was certified against Streptococcus pneumonia to be used in children. In Cuba, in spite of the efforts, the anti-pneumococcal vaccine has not been introduced and for more of a decade time scientists have been working in a heptavalent conjugated vaccine, currently in an advanced clinical evaluation. In this work, considerations in this regard are made.

REFERENCES

1. Liu L, Oza S, Hogan D, Perin J, Rudan I, Lawn J, et al. Global, regional, and national causes of child mortality in 2000–13, with projections to inform post-2015 priorities: an updated systematic analysis. Lancet. 2014 ; 385 (9966): 430-40.

2. Gisselsson M. Trends in Otitis Media incidence after Conjugate Pneumococcal Vaccination: A National Observational Study. Pediatr Infect Dis J. 2017 ; 36 (11): 1027-31.

3. Bernaola E, Gil F, Herranz M, Gil-Setas A, Guevara M, Castilla J. Pneumococcal Vaccination and Pneumonia Associated With Pleural Effusion in a Pediatric Population. Pediatr Infect Dis J. 2018 ; 37 (4): e87-92.

4. Dickinson F, Rodríguez M, Toraño G. Pneumococcal meningitis in Cuban children and adolescents: A fifteen years follow up. Pediatrics Research International Journal [revista en Internet]. 2015 [ cited 18 Oct 2018 ] ; 2015 (2015): [aprox. 22p]. Available from: https://ibimapublishing.com/articles/PRIJ/2015/59 6251/596251.pdf.

5. Toraño G, Suárez D, Abreu M, Barreto B, Toledo M, Linares N. Serotipos de Streptococcus pneumoniae responsables de enfermedad invasiva en niños cubanos. Rev Cubana Pediatr [revista en Internet]. 2017 [ cited 18 Oct 2018 ] ; 89 (sup): [aprox. 12p]. Available from: http://www.revpediatria.sld.cu/index.php/ped/arti cle/view/151/110.

6. Diao W, Shen N, Yu P, Liu B, He B. Efficacy of 23-valent pneumococcal polysaccharide vaccine in preventing community acquired pneumonia among immunocompetent adults: A systematic review and meta-analysis of randomized trials. Vaccine. 2016 ; 34 (13): 1496-503.

7. Balsells E. Serotype Distribution of Streptococcus Pneumoniae Causing Invasive Disease in Children in the Post-Pcv Era: A Systematic Review and Meta-Analysis. PLosOne. 2017 ; 12 (5): e0177113.

8. Dotres C, Puga R, Ricardo Y, Brono C, Paredes B, Echemendia V, et al. Safety and preliminary immunogenicity of Cuban pneumococcal conjugate vaccine candidate in healthy children: A randomized phase I clinical trial. Vaccine. 2014 ; 32 (41): 5266-70.

9. Pichichero M, Nadeem M, Xu Q. Next generation protein based Streptococcus pneumoniae vaccines. Hum Vaccin Immunother. 2016 ; 12 (1): 194-205.

10. Croxtall JD, Keating GM. Pneumococcal polysaccharide protein D-conjugate vaccine (Synflorix™; PhiD-CV). Pediatric Drugs. 2009 ; 11 (5): 349-57.